Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. These ads promote diagnostic testing and hormone care; no peptide-specific active creative was observed in the sampled libraries. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A focused lab-testing page pairs a direct entry offer with testing details, care steps and supporting information. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The ad gives the viewer a new idea, which is rarer than it should be: a protein called SHBG can bind testosterone, so a normal total number might not tell the whole story. That makes the test feel necessary rather than optional, and it ties directly to the caption, which lists free testosterone and SHBG among the markers. The split screen (talking head above, training footage below) keeps the eye busy for a full minute. The closing line, “maybe you’re not broken, you’re just trapped,” mirrors Joi’s “not broken” copy on the women’s side.
Some lines are bigger claims than the ad supports: the creator says “most doctors never even check it” and describes feeling sharper with drive back, all as his own account. There’s no price on screen, and once the viewer clicks, the page’s hero talks about 110 biomarkers but doesn’t mention SHBG or free testosterone near the top, so the idea that hooked them disappears. If you make one like this, add a price card and send it to a page section that names the exact markers the video explained.
It promises a reveal and puts the audience’s world (training) on screen.
It teaches a mechanism the viewer likely hasn’t heard, which makes testing feel necessary.
It connects the idea to the product and spells out what happens after the test.
It removes cost objections and ends on a line that lifts blame off the viewer.
The caption offers 65% off, $150 down to $52.50 for the Complete Panel. The video mentions no membership fee and HSA/FSA eligibility but no price.
The ad lands on the Blokes lab landing page, a focused page that sits a rung above a product page. It confirms the clinician visit (30-60 minutes in the hero), the discount badge and the three-step process the creator describes. But the specific hook (SHBG and free testosterone) isn’t visible in the hero or the What Blokes offers list, and the Select A Lab cards only show biomarker counts. A short section naming the markers in each panel, with SHBG and free T called out, would keep the viewer’s new idea alive after the click.
The Blokes men’s lab-testing landing page leads with “Analyze up to 110 biomarkers” and a 65% new-customer badge, then covers what Blokes offers, a three-step process, a customer quote, three panels from $52.15, reviews and FAQs. 8 ads in the Fluid library send people here, from creator testimonials and a Stipe Miocic warning to typographic statics.
It announces 65% off labs for new customers, answering “is there a deal?”
Up to 110 biomarkers, the 65% badge, a lab selector and the clinician consultation answer “what is this and what do I get?”
Vogue, Vice, Men’s Health, Forbes, Esquire and others answer “has anyone heard of this?”
A list of inclusions and a “Test my biomarkers” button answer “what comes with the test?”
Lab test, clinician consultation and treatment answer “what’s the process?”
Michael Eckert on learning what his body needs answers “has this worked for someone like me?”
Three badged panels at $52.15, $139.65 and $244.65 answer “which one should I buy?”
Short quotes under “Real people, real results” add customer voices.
Questions on preparation, results timing, insurance and HSA/FSA answer the logistics.
A closing email field captures visitors who aren’t ready to buy.
Read the full breakdown of this page
One of 18 Joi + Blokes ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.